Skip to main content
Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

1 Aufruf
Herunterladen
Pharmazeutisch

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.

Dosierung

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Stärke

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Packungsgröße

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Form

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Sicherheitsprofil

Kontraindikationen

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Nebenwirkungen

Evoltra-H-C-613-PSUV-0044: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Verwandte klinische Artikel

Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.

QR Code